Navigation Links
Consistent, Managed Treatment Works Best for Children With AD/HD
Date:11/16/2007

LANDOVER, Md., Nov. 16 /PRNewswire-USNewswire/ -- According to the recently released follow-up study to the Multimodal Treatment Study on Attention-Deficit/Hyperactivity Disorder (MTA) in the August issue of the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), children and young people with AD/HD who received carefully managed medication alone or in combination with behavioral management and educational adaptations fared better than children who did not. However, study participants who no longer received intensive interventions and returned to standard community-based care had lost the initial advantages after three years.

These findings show highly intensive treatment works best when begun early and consistently maintained. If high quality treatment is not continued, the initial benefits may be lost several years later. Lead researcher Peter Jensen, M.D., has emphasized the need for parents and healthcare providers to work closely together for the benefit of the child affected by AD/HD. Unfortunately, recent reports in the media have misrepresented the MTA's findings and drawn unsubstantiated conclusions.

CHADD, Children and Adults with Attention-Deficit/Hyperactivity Disorder, encourages each family to work with their healthcare providers for the most effective treatment for their families and children affected by AD/HD.

To read an interview with Jensen concerning the findings, go to http://www.chadd.org/AM/Template.cfm?Section=Press_Releases1&Template=/CM/C ontentDisplay.cfm&ContentID=5158.


'/>"/>
SOURCE CHADD
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Partners Rx Chief Pharmacy Officer, Richard Bullard on Panel Discussion at the Fall 2007 Managed Markets Summit (MMS) in Phoenix, AZ.
2. Fingertip Formulary Restrictions(TM) Provides Unprecedented Access to Real- Time Managed Care Restrictions Data
3. Medicaid Managed Care Seems to Fall Short
4. States Largest Medicaid Managed Care Plan Offering Training to Combat West Virginia Obesity Epidemic
5. New treatment effective in counteracting cocaine-induced symptoms
6. New treatment boosts muscle function in myasthenia gravis
7. Broad-based group of physicians calls for improvement in stroke treatment
8. Cranberry Could Juice Up Ovarian Cancer Treatment
9. Non-medicinal treatment touted for pre-schoolers with ADHD
10. Nonmedicinal treatment touted for preschoolers with ADHD
11. U of M study: Early treatment can reverse heart damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... Switzerland (PRWEB) , ... January 23, 2017 , ... ... lab and production applications. However, choosing the right method is paramount to success. ... occur more often in situations where multiple persons use the same equipment. Rare ...
(Date:1/23/2017)... ... 2017 , ... Old School Labs™, makers of the wildly popular all-natural sports ... Ansley to its growing team of brand ambassadors. The Olympia top finisher and former ... than a year was able to turn professional, participating in the 2013 NPC USA ...
(Date:1/23/2017)... ... ... at the Mill”: a story of love and redemption, hope and uncertainty as a ... , “The Inn at the Mill” is the creation of published author, Lois Kulp, ... now living in Berks County on Crow Hill. The inn, the mill and ...
(Date:1/23/2017)... ... ... “Life Under Blankets”: an entrancing story about one woman's travels through the wilderness ... of published author, Kimberly Mitchell, who earned her bachelor’s degree in English education at ... master’s degree in education in the field of curriculum and instruction. Kimberly’s passion for ...
(Date:1/22/2017)... FRANCE (PRWEB) , ... January 22, 2017 , ... Phytocéane ... Ocean, isolated from the rest of the world with ZANZIBAR MILKY CREAM. Inspired by ... used key ingredients like Virgin Coconut Oil and moisturizing vegetal coral to create this ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... PALMA, Spain , January 23, ... a clinical-stage biopharmaceutical company focused on treatments for ... has been enrolled in the Phase IIb "CaLIPSO ... the treatment of cardiovascular calcification (CVC) in end-stage-renal-disease ... ESRD patients, in the last stage of chronic ...
(Date:1/21/2017)... , Jan 20, 2017 Research ... Clinical Laboratory Testing Market By Type of Test (Tumor, Clinical ... & By Type of Diseases (Tuberculosis, Influenza, Cancer, HIV/AIDS etc.), ... ... attractive destination for healthcare services, market segments, especially clinical lab ...
(Date:1/21/2017)... -- Research and Markets has announced the addition of ... Route Of Administration, End User - Forecast to 2025" report ... ... a CAGR of around 7.8% over the next decade to reach ... analyzes the global markets for Advanced Drug Delivery across all the ...
Breaking Medicine Technology: